Keywords
COVID-19
Critical care
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To highlight the impacts of using Extracorporeal Membrane Oxygenation (ECMO) in critically ill patients with COVID-19. Methods: This is an integrative review of a descriptive and exploratory nature, carried out in March 2024. This research was guided by the PICO strategy. The search was conducted using the following databases: LILACS and MEDLINE via VHL and Embase via the Cochrane Library. Thus, MeSH were selected as descriptors, both being crossed by the Boolean operator AND. Inclusion and exclusion criteria were used. Therefore, 10 studies were selected. Results: According to most studies, early ECMO support, compared to conventional management, significantly improves patient survival. However, although ECMO has demonstrated its ability to save lives in individuals with severe COVID-19, the available data from the selected studies are still insufficient in terms of determining its effectiveness, understanding the impacts and identifying ideal candidates who benefit from this treatment. Final considerations: It was found that the most recent research demonstrated a possible benefit of ECMO, as it resulted in lower mortality in critically ill patients with COVID-19.
References
BARBARO RP, et al. Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry. The Lancet, 2021; 398(10307): 1230-1238.
BARBARO RP, et al. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry. The Lancet, 2020; 396(10257): 1071-1078.
BRASIL. Ministério da Saúde. Política Nacional de Gestão de Tecnologias em Saúde. Brasília: Ministério da Saúde, 2021.
BERGMAN ZR, et al. The use of venovenous extracorporeal membrane oxygenation in COVID-19 infection: One region’s comprehensive experience. Asaio Journal, 2021; 67(5): 503-510.
BERTINI P, et al. ECMO in COVID-19 patients: a systematic review and meta-analysis. Journal of cardiothoracic and vascular anesthesia, 2022; 36(8): 2700-2706.
DIAZ RA, et al. Extracorporeal membrane oxygenation for COVID-19–associated severe acute respiratory distress syndrome in Chile: a nationwide incidence and cohort study. American journal of respiratory and critical care medicine, 2021; 204(1): 34-43.
FANG J, et al. Extracorporeal membrane oxygenation therapy for critically ill coronavirus disease 2019 patients in Wuhan, China: a retrospective multicenter cohort study. Current Medical Science, 2021; 41: 1-13.
GARFIELD BE, et al. A comparison of long-term outcomes in patients managed with venovenous extracorporeal membrane oxygenation in the first and second waves of the COVID-19 pandemic in the United Kingdom. Critical Care Medicine, 2023; 51(8): 1064-1073.
GATTINONI L, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes?. Intensive care medicine, 2020; 46: 1099-1102.
GIRAUD R, et al. Timing of VV‐ECMO therapy implementation influences prognosis of COVID‐19 patients. Physiological reports, 2021; 9(3): 14715.
JOSHI DR, et al. Epidemiology and outcomes of infections during extracorporeal membrane oxygenation in adult patients with COVID-19 ARDS-A single center study. Indian Journal of Medical Microbiology, 2024; 48: 100539.
KIM JH, et al. Venovenous ECMO treatment, outcomes, and complications in adults according to large case series: A systematic review. The International Journal of Artificial Organs, 2021; 44(7): 481-488.
LI X, et al. Extracorporeal membrane oxygenation for coronavirus disease 2019 in Shanghai, China. Asaio Journal, 2020; 66(5): 475-481.
LORUSSO R, et al. ECMO for COVID-19 patients in Europe and Israel. Intensive care medicine, 2021; 47: 344-348.
MÁSSIMO EAL, et al. Uso de ECMO no COVID-19: relato de caso de ECMO venovenosa em paciente adulto com COVID-19. Enfermagem revista, 2021; 24(2).
MUNSHI L, et al. Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis. The Lancet Respiratory Medicine, 2019; 7(2): 163-172.
REDAELLI MB, et al. Novel coronavirus disease (COVID-19) in Italian patients: Gender differences in presentation and severity. Saudi Journal of Medicine & Medical Sciences, 2021; 9(1): 59-62.
RAMANATHAN K, et al. Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis. Critical care, 2021; 25: 1-11.
SHAEFI S, et al. Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19. Intensive care medicine, 2021; 47: 208-221.
SHEKAR K, et al. Extracorporeal life support organization coronavirus disease 2019 interim guidelines: a consensus document from an international group of interdisciplinary extracorporeal membrane oxygenation providers. Asaio Journal, 2020; 66(7): 707-721.
SMITH, DE, et al. One-year outcomes with venovenous extracorporeal membrane oxygenation support for severe COVID-19. The Annals of Thoracic Surgery, 2022; 114(1): 70-75.
SOUZA SC. Revisão integrativa: o que é e como fazer. Einstein (São Paulo), (2010); 8: 102-106.
SUPADY A, et al. Survival after extracorporeal membrane oxygenation in severe COVID-19 ARDS: results from an international multicenter registry. Critical Care, 2021; 25: 1-4.
TREJNOWSKA E, et al. (2022). Extracorporeal membrane oxygenation for severe COVID-19-associated acute respiratory distress syndrome in Poland: a multicenter cohort study. Critical Care, 2022; 26(1): 97.
YANG X, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The lancet respiratory medicine, 2020; 8(5): 475-481.
ZOCHIOS BP. Toward precision delivery of ECMO in COVID-19 cardiorespiratory failure. ASAIO Journal, 2020; 66(7): 731-733.